About this trial
The purpose of this study was to evaluate the efficacy of 1 capsules of ABKefir per day on symptoms of constipation in subjects with functional constipation by clinical trial.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
male or female
aged 18-75 years old
fulfill Rome IV criteria for functional constipation
have not participated in similar research in the past three months
Disqualifiers
Personal or family history of colon cancer, celiac disease, and inflammatory bowel disease
Irritable bowel syndrome diagnosed during colonoscopy
Those who are pregnant recently (including men and women), or are pregnant or breastfeeding women.
Taking antidepressants, anti-anxiety drugs and other psychotropic drugs.
Trial design
Parallel
Treatments tested in this trial
Placebo
Dietary supplementTake a capsule of placebo within 30 minutes after breakfast, and once a day.
Probiotics (ABKefir)
Dietary supplementTake a capsule of ABKefir within 30 minutes after breakfast, and once a day.
Treatment groups
Trial outcomes
Primary outcomes
Change from baseline symptoms of constipation at week 4 and 8
Compared the difference of bowel movements between the week 0, 4 and 8.
Change from baseline symptoms of constipation at week 4 and 8
Compared the difference of stool consistency between the week 0, 4 and 8.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Chung Shan Medical University
Lead sponsor
SYNBIO TECH INC. Kaohsiung Taiwan
Collaborator